T. Rowe Price Investment Management
RAPT

T. Rowe Price Investment Management’s RAPT Therapeutics RAPT Stock Holding History

T. Rowe Price Investment Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-159,733
Closed -$31.8M – 652
2023
Q4 		$31.8M Buy
159,733
+3,246
+2% +$402K 0.02% 447
2023
Q3 		$20.8M Buy
156,487
+1,164
+0.7% +$190K 0.01% 472
2023
Q2 		$23.2M Buy
155,323
+1,350
+0.9% +$210K 0.02% 463
2023
Q1 		$22.6M Sell
153,973
-1,994
-1% -$403K 0.02% 459
2022
Q4 		$24.7M Buy
155,967
+383
+0.2% +$61.3K 0.02% 436
2022
Q3 		$29.9M Buy
+155,584
New +$29.4M 0.02% 406

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return